EarningsNxt
CalendarInsightsFor AgentsAbout
EarningsNxt

Earnings briefings in plain English, before and after the bell. Free calendar, Pro briefs at $8/mo.

Get briefs in your inbox For agents

Popular tickers

AAPLMSFTGOOGLAMZNNVDAMETATSLAJPMVUNHJNJWMT

Product

  • Earnings Calendar
  • Pricing
  • For Agents

Resources

  • Insights
  • API Reference
  • FAQ
  • llms.txt

Company

  • About
  • Contact
  • X / Twitter
  • StockTwits
  • Instagram

© 2026 EarningsNxt. For informational purposes only. Not financial advice. AI-assisted content may contain errors.

Terms of ServicePrivacy PolicyDisclaimerDisclosureAccessibilityDo Not Sell My Info
  1. Home
  2. ALKS

Equity Profile

ALKS

Alkermes plc

Health CareBiotechnology$6.7B market cap

Earnings scorecard

Last 73Q

EPS beat streak

2Q

EPS beat rate

81%

Avg EPS surprise

+178.93%

Avg 1-day reaction

-0.36%

Earnings history

74 quarters
Full history
QuarterReportedEst.ActualSurprise1-day
Q3-2026UpcomingOct 28, 2026$0.25———Preview
Q2-2026Jul 28, 2026$-0.04$0.00+100.00%-4.23%Preview
Q1-2026May 5, 2026$-0.04$-0.40+30.31%+6.09%Preview
Q4-2025Feb 25, 2026$0.31$0.29-6.45%-7.04%Preview
Q3-2025Oct 28, 2025$0.34$0.49+42.86%+4.31%Preview
Q2-2025Jul 29, 2025ProPreview
Q1-2025May 1, 2025ProPreview
Q4-2024Feb 12, 2025ProPreview
Q3-2024Oct 24, 2024ProPreview
Q2-2024Jul 24, 2024ProPreview
Q1-2024May 1, 2024ProPreview
Q4-2023Feb 15, 2024ProPreview
Q3-2023Oct 25, 2023ProPreview
Q2-2023Jul 26, 2023ProPreview
Q1-2023Apr 26, 2023ProPreview
Q4-2022Feb 16, 2023ProPreview
Q3-2022Nov 2, 2022ProPreview
Q2-2022Jul 27, 2022ProPreview
Q1-2022Apr 27, 2022ProPreview
Q4-2021Feb 16, 2022ProPreview
Q3-2021Oct 27, 2021ProPreview
Q2-2021Jul 28, 2021ProPreview
Q1-2021Apr 28, 2021ProPreview
Q4-2020Feb 11, 2021ProPreview
Q3-2020Oct 29, 2020ProPreview
Q2-2020Jul 29, 2020ProPreview
Q1-2020Apr 29, 2020ProPreview
Q4-2019Feb 13, 2020ProPreview
Q3-2019Oct 23, 2019ProPreview
Q2-2019Jul 25, 2019ProPreview
Q1-2019Apr 25, 2019ProPreview
Q4-2018Feb 14, 2019ProPreview
Q3-2018Oct 23, 2018ProPreview
Q2-2018Jul 26, 2018ProPreview
Q1-2018Apr 26, 2018ProPreview
Q4-2017Feb 14, 2018ProPreview
Q3-2017Oct 26, 2017ProPreview
Q2-2017Jul 27, 2017ProPreview
Q1-2017Apr 27, 2017ProPreview
Q4-2016Feb 15, 2017ProPreview
Q3-2016Nov 2, 2016ProPreview
Q2-2016Jul 28, 2016ProPreview
Q1-2016Apr 28, 2016ProPreview
Q4-2015Feb 25, 2016ProPreview
Q3-2015Oct 29, 2015ProPreview
Q2-2015Jul 30, 2015ProPreview
Q1-2015Apr 30, 2015ProPreview
Q4-2014Feb 24, 2015ProPreview
Q3-2014Oct 29, 2014ProPreview
Q2-2014Jul 31, 2014ProPreview
Q1-2014Apr 30, 2014ProPreview
Q4-2013May 23, 2013ProPreview
Q3-2013Jan 31, 2013ProPreview
Q2-2013Nov 1, 2012ProPreview
Q1-2013Jul 26, 2012ProPreview
Q4-2012May 17, 2012ProPreview
Q3-2012Feb 2, 2012ProPreview
Q2-2012Nov 3, 2011ProPreview
Q1-2012Aug 1, 2011ProPreview
Q4-2011May 18, 2011ProPreview
Q3-2011Feb 3, 2011ProPreview
Q2-2011Nov 4, 2010ProPreview
Q1-2011Aug 5, 2010ProPreview
Q4-2010May 13, 2010ProPreview
Q3-2010Feb 4, 2010ProPreview
Q2-2010Nov 5, 2009ProPreview
Q1-2010Aug 6, 2009ProPreview
Q4-2009May 21, 2009ProPreview
Q3-2009Feb 5, 2009ProPreview
Q2-2009Nov 6, 2008ProPreview
Q1-2009Aug 7, 2008ProPreview
Q4-2008May 22, 2008ProPreview
Q3-2008Feb 7, 2008ProPreview
Q2-2008Nov 1, 2007ProPreview

Next report

Q3-2026

Wed, Oct 28

Before the open

Est. EPS

$0.25

Est. Rev

$465M

Read the preview

About ALKS

Sector
Health Care
Industry
Biotechnology
Market cap
$6.7B

69 earlier quarters of EPS results and stock reactions are part of Pro.

No charge today · $8/mo after 7 days · Cancel anytime

Q2-2025Jul 29, 2025ProPreview
Q1-2025May 1, 2025ProPreview
Q4-2024Feb 12, 2025Pro
Preview
Q3-2024Oct 24, 2024ProPreview
Q2-2024Jul 24, 2024ProPreview
Q1-2024May 1, 2024ProPreview
Q4-2023Feb 15, 2024ProPreview
Q3-2023Oct 25, 2023ProPreview
Q2-2023Jul 26, 2023ProPreview
Q1-2023Apr 26, 2023ProPreview
Q4-2022Feb 16, 2023ProPreview
Q3-2022Nov 2, 2022ProPreview
Q2-2022Jul 27, 2022ProPreview
Q1-2022Apr 27, 2022ProPreview
Q4-2021Feb 16, 2022ProPreview
Q3-2021Oct 27, 2021ProPreview
Q2-2021Jul 28, 2021ProPreview
Q1-2021Apr 28, 2021ProPreview
Q4-2020Feb 11, 2021ProPreview
Q3-2020Oct 29, 2020ProPreview
Q2-2020Jul 29, 2020ProPreview
Q1-2020Apr 29, 2020ProPreview
Q4-2019Feb 13, 2020ProPreview
Q3-2019Oct 23, 2019ProPreview
Q2-2019Jul 25, 2019ProPreview
Q1-2019Apr 25, 2019ProPreview
Q4-2018Feb 14, 2019ProPreview
Q3-2018Oct 23, 2018ProPreview
Q2-2018Jul 26, 2018ProPreview
Q1-2018Apr 26, 2018ProPreview
Q4-2017Feb 14, 2018ProPreview
Q3-2017Oct 26, 2017ProPreview
Q2-2017Jul 27, 2017ProPreview
Q1-2017Apr 27, 2017ProPreview
Q4-2016Feb 15, 2017ProPreview
Q3-2016Nov 2, 2016ProPreview
Q2-2016Jul 28, 2016ProPreview
Q1-2016Apr 28, 2016ProPreview
Q4-2015Feb 25, 2016ProPreview
Q3-2015Oct 29, 2015ProPreview
Q2-2015Jul 30, 2015ProPreview
Q1-2015Apr 30, 2015ProPreview
Q4-2014Feb 24, 2015ProPreview
Q3-2014Oct 29, 2014ProPreview
Q2-2014Jul 31, 2014ProPreview
Q1-2014Apr 30, 2014ProPreview
Q4-2013May 23, 2013ProPreview
Q3-2013Jan 31, 2013ProPreview
Q2-2013Nov 1, 2012ProPreview
Q1-2013Jul 26, 2012ProPreview
Q4-2012May 17, 2012ProPreview
Q3-2012Feb 2, 2012ProPreview
Q2-2012Nov 3, 2011ProPreview
Q1-2012Aug 1, 2011ProPreview
Q4-2011May 18, 2011ProPreview
Q3-2011Feb 3, 2011ProPreview
Q2-2011Nov 4, 2010ProPreview
Q1-2011Aug 5, 2010ProPreview
Q4-2010May 13, 2010ProPreview
Q3-2010Feb 4, 2010ProPreview
Q2-2010Nov 5, 2009ProPreview
Q1-2010Aug 6, 2009ProPreview
Q4-2009May 21, 2009ProPreview
Q3-2009Feb 5, 2009ProPreview
Q2-2009Nov 6, 2008ProPreview
Q1-2009Aug 7, 2008ProPreview
Q4-2008May 22, 2008ProPreview
Q3-2008Feb 7, 2008ProPreview
Q2-2008Nov 1, 2007ProPreview